Design Therapeutics (DSGN) Operating Leases (2021 - 2026)
Design Therapeutics (DSGN) recorded Operating Leases of $2.03 million in Q2 2026, up 84.3% from $1.1 million a year earlier but down 7.6% from the prior quarter.
Powered by 
Analysis
Design Therapeutics (DSGN) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Design Therapeutics reported Operating Leases of $645,000, down 58.0% from FY2024.
- Annual Operating Leases has declined for four straight years, with a four-year compound annual growth rate of -32.7% (FY2021 to FY2025).
- Across earlier years, Operating Leases came in at $1.53 million in FY2024 (-34.3%), $2.33 million in FY2023 (-23.5%), $3.05 million in FY2022 (-3.0%) and $3.14 million in FY2021.
- Quarterly Operating Leases has ranged from $645,000 in Q4 2025 to $3.38 million in Q2 2022 over the past five years.
- On a year-over-year basis, Operating Leases rose in two of the last eight quarters, with an average decline of 13.0%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 84.3% in Q2 2026, against a decline of 58.0% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.2 million (Q1 2026), $645,000 (Q4 2025) and $877,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Design Therapeutics | 669.43 Mn | -186.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 877,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 2.88 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.27 Mn |
API Access
Design Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();